Eupraxia PharmaceuticalsEPRX
13F holders, Q4 2025 (December 31)36holders +9
13new positions
6sold out
1famous investor
$7.53avg. 13F price*
At the end of Q4 2025, 36 institutions reported holding Eupraxia Pharmaceuticals Inc. (EPRX) in their 13F filings, up 9 from Q3 2025. 13 opened new positions and 6 sold out. The largest holders were Beutel, Goodman & Co Ltd. ($27.9M), Vivo Capital, LLC ($10.2M) and Balyasny Asset Management L.P. ($10.2M). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Eupraxia Pharmaceuticals Inc.
- CUSIP
- 29842P105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $16.9M |
| Exits | 6 | $7.1M |
All 13F filers, Q3 2025 → Q4 2025: 2,819,188 shares bought and 2,302,060 shares sold, net +517,128 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| Beutel, Goodman & Co Ltd. | 0.17% | Reduce -8.6% | 3,709,373 | $27.9M |
| Vivo Capital, LLC | 0.66% | No change | 1,350,000 | $10.2M |
| Balyasny Asset Management L.P. | 0.02% | No change | 1,350,000 | $10.2M |
| Scotia Capital Inc. | 0.04% | Add +0.7% | 1,286,183 | $9.6M |
| Great Point Partners LLC | 2.94% | No change | 1,200,000 | $9.1M |
| Point72 Asset Management | 0.01% | New | 712,104 | $5.4M |
| Ikarian Capital, LLC | 0.60% | New | 610,000 | $4.6M |
| Squadron Capital Management LLC | 1.68% | — | 500,000 | $3.8M |
| Ally Bridge Group (NY) LLC | 4.77% | Reduce -56.5% | 397,895 | $3.0M |
| Velan Capital Investment Management LP | 1.55% | No change | 352,000 | $2.7M |
| Affinity Asset Advisors, LLC | 0.17% | No change | 300,000 | $2.3M |
| Arrowstreet Capital, Limited Partnership | 0.00% | New | 278,064 | $2.1M |
| Bank of America Corp. | 0.00% | Add +455.8% | 253,321 | $1.9M |
| UBS Group AG | 0.00% | Add +129.8% | 220,024 | $1.7M |
| Royal Bank of Canada | 0.00% | Reduce -54.2% | 196,277 | $1.5M |
| SummitTX Capital, L.P. | 0.04% | New | 175,948 | $1.3M |
| Marshall Wace, LLP | 0.00% | New | 158,133 | $1.2M |
| Boothbay Fund Management, LLC | 0.03% | New | 156,331 | $1.2M |
| Acadian Asset Management LLC | 0.00% | Add +627.9% | 155,766 | $1.2M |
| Delaney Capital Management Ltd. | 0.15% | — | 119,400 | $899K |
| Ingalls & Snyder LLC | 0.02% | Add +31.0% | 77,400 | $584K |
| Goldman Sachs Group Inc. | 0.00% | Add +44.8% | 58,058 | $438K |
| Cibc World Market Inc. | 0.00% | Add +287.0% | 58,050 | $437K |
| Raymond James Financial Inc. | 0.00% | Add +58.7% | 52,972 | $400K |
| Quadrature Capital Ltd | 0.00% | New | 43,186 | $326K |
| Bank of Montreal | 0.00% | No change | 37,250 | $280K |
| 1832 Asset Management L.P. | 0.00% | New | 32,138 | $243K |
| Jane Street Group, LLC | 0.00% | New | 29,622 | $223K |
| XTX Topco Ltd | 0.00% | New | 16,180 | $122K |
| Geode Capital Management, LLC | 0.00% | New | 13,899 | $105K |
| TCI Wealth Advisors, Inc. | 0.00% | No change | 11,000 | $83K |
| Guardian Wealth Advisors, LLC / NC | 0.00% | New | 10,000 | $76K |
| Aptus Capital Advisors, LLC | 0.00% | New | 10,000 | $76K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 9,600 | $72K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 9,091 | $68K |
| National Bank of Canada | 0.00% | Reduce -33.6% | 586 | $4K |
"% of holder's portfolio" is EPRX's weight in each manager's 13F, not the share of Eupraxia Pharmaceuticals Inc. the manager owns.